Magnetic Syringe Foaming Element for Sclerotherapy

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing sclerotherapy techniques using liquid sclerosing solutions are unpredictable and difficult to automate, as they dilute upon injection into veins, whereas sclerosing foams provide more predictable results but are cumbersome to generate.

Innovation Solution

A foaming chamber with a magnetically or electrostatically driven impeller within a syringe barrel that creates foam by moving the impeller through the vascular treatment fluid, allowing for contactless agitation and efficient foam generation.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If liquid sclerosing solution is injected into veins, then the injection process is simple, but the solution dilutes in blood causing unpredictable results

Engineering Contradiction:
Improvepredictability of treatment resultsVSAvoiddrug concentration
Core Design Contradiction:
ReliabilityVSQuantity of substance

Solution Approach 1:

The invention transforms the sclerosing solution from liquid phase to foam phase by incorporating gas bubbles. This phase transition allows the sclerosing agent to maintain higher concentration and resist dilution when injected into blood, as the foam structure preserves the liquid-gas mixture integrity better than pure liquid form.

Inventive Principle:
Principle #36Phase transitions

Solution Approach 2:

The invention creates a composite foam material combining sclerosing solution with gas bubbles. This composite structure provides both the therapeutic effect of the sclerosing agent and the stability of foam formulation, enabling controlled delivery and reduced dilution in the bloodstream.

Inventive Principle:
Principle #40Composite materials

2Reliability

If sclerosing foam is used instead of liquid solution, then treatment predictability improves, but foam generation becomes cumbersome and difficult to automate

Engineering Contradiction:
Improvepredictability of treatment resultsVSAvoidease of foam generation
Core Design Contradiction:
ReliabilityVSExtent of automation

Solution Approach 1:

The invention replaces complex mechanical foam generation systems with a simple syringe-based manual system. The foam is generated by shaking or agitating the sclerosing solution within the syringe barrel, eliminating the need for complex automated foam generators while maintaining foam quality and treatment predictability.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The system allows the operator to generate foam directly in the syringe by simple manual agitation. The syringe itself serves as both the container and the foam generation chamber, requiring no additional specialized equipment or complex automated mechanisms.

Inventive Principle:
Principle #25Self-service

3Device complexity

If manual foam generation methods are used, then device complexity is reduced, but the process becomes difficult to standardize and automate

Engineering Contradiction:
Improvesimplicity of foam generation deviceVSAvoidstandardization of process
Core Design Contradiction:
Device complexityVSEase of manufacture

Solution Approach 1:

The syringe serves multiple functions: it stores the sclerosing solution, generates the foam through manual agitation, and delivers the foam for injection. This multi-functionality simplifies the overall device while maintaining standardization, as syringes are universally available and their use is easily standardized in medical practice.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This method enables the production of a stable, predictable foam that can be injected directly into veins, reducing the need for high drug doses and minimizing decomposition time, thus improving the efficacy of sclerotherapy treatments.

Implementation Method 1

a magnetic drive unit configured to magnetically engage the foaming element

Methodology Applied
Scientific EffectMagnetic coupling: Magnetism

Implementation Method 2

a drive unit can alternatively be configured to electrostatically couple to said foaming element

Methodology Applied
Scientific EffectElectrostatic coupling: Electrostatics

Implementation Method 3

The foaming element can have one or more flow passages therein so that movement of the foaming element in the vascular treatment fluid tends to force the fluid through the one or more flow passages

Methodology Applied
Scientific EffectFluid flow through passages:

Data Source

PatentUS8469924B2Method and apparatus for generating vascular treatment foam
Publication Date: 2013.06.25 COVIDIEN LP
  • US8469924B2 patent drawing
  • US8469924B2 patent drawing
  • US8469924B2 patent drawing

AI summary

Apparatus and methods for generating foam are disclosed. The inventions can be used for generating foam for sclerotherapy. A foaming element can be agitated within a foaming chamber by a drive unit that does not touch the foaming element, but actuates it from outside the foaming chamber. The foaming element and drive unit can be magnetically coupled. A syringe can be used to form a foaming chamber.